Whole Genome Sequencing News and Research

RSS

Older heart muscle cells accumulate new genetic mutations -; while losing the ability to repair them

Why does the risk of heart disease go up as we age? Known risk factors such as hypertension or high cholesterol don't explain all cases.

12 Aug 2022

Mount Sinai and Regeneron Genetics Center launch a new human genome sequencing research project

Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai have launched a new human genome sequencing research project called the Mount Sinai Million Health Discoveries Program with the Regeneron Genetics Center (RGC), part of the industry-leading, New York-based biotechnology company Regeneron.

12 Aug 2022

What is the genomic diversity of SARS-CoV-2 infections in households?

In a new study, researchers assessed the genomic diversity of SARS-CoV-2 in households.

12 Aug 2022

Nearly three-quarters of all stem cell lines are affected by DNA damage, say researchers

DNA damage caused by factors such as ultraviolet radiation affect nearly three-quarters of all stem cell lines derived from human skin cells, say Cambridge researchers, who argue that whole genome sequencing is essential for confirming if cell lines are usable.

11 Aug 2022

A direct lineage-typing RT-PCR assay reveals insights into the transition from Omicron BA.1 to BA.2 dominance in Sweden

Researchers monitored the remarkably rapid Omicron BA.1 to BA.2 sublineage dominance transition in the Swedish population in early 2022 on a day-to-day basis using a customized lineage-typing RT-PCR assay.

10 Aug 2022

Evaluating vaccine effectiveness against Omicron BA.5 and BA.2 in Portugal

Researchers estimated the vaccine effectiveness (VE) of the primary and booster doses of COVID-19 vaccines against reinfection by Omicron BA.5 and BA.2 lineages and severe post-infection outcomes.

9 Aug 2022

Serbia's genome center monitors potential virus mutations to facilitate more effective COVID-19 control

In partnership with BGI Genomics from China, Serbia's first genome sequencing center, opened in December 2021, is monitoring potential virus mutations to facilitate more effective COVID-19 control and accelerating access to genomics to enhance health outcomes.

9 Aug 2022

Insights into the products and services of Azenta

This interview talks to Andre Kotze about the different services and products available at Azenta.

From Azenta Life Sciences 8 Aug 2022

Early-life acquisition of antibiotic resistance in neonates from developing countries

Every year, almost 7 million potentially serious bacterial infections are estimated to occur in newborns, resulting in more than 550,000 annual neonatal deaths.

4 Aug 2022

Disease progression in the rhesus macaque model upon inoculation with the Delta, Omicron BA.1, and Omicron BA.2 variants

Researchers compared the severity levels of disease caused by different SARS-CoV-2 variants of concern in the rhesus macaque model.

4 Aug 2022

Children with intellectual disability of genetic origin are extremely likely to develop other neuropsychiatric conditions

A major study of children with intellectual disabilities has highlighted the additional challenges that they often face, including a much-increased likelihood of being diagnosed as autistic, as well as Attention Deficit Hyperactivity Disorder (ADHD) and other mental health difficulties.

3 Aug 2022

What is the prevalence of carbapenem-resistant Enterobacterales among individuals with and without health risk factors?

Researchers assessed carbapenem-resistant Enterobacterales (CRE) epidemiology across eight US metropolitan areas between 1 January 2012 and 31 December 2015.

3 Aug 2022

How and when do de novo SARS-CoV-2 spike mutations emerge?

Researchers evaluated viral mutations in two patients with persistent SARS-CoV-2 infection.

1 Aug 2022

Comparing SARS-CoV-2 Omicron BA.2 and BA.5 vaccine breakthrough infections

In a new study, investigators explored the SARS-CoV-2 Omicron BA.2 and BA.5 vaccine breakthrough infection likelihood.

28 Jul 2022

Researchers assess UK biobank genome sequences

In a new study, researchers analyzed 150,119 genome sequences from the United Kingdom Biobank (UKB).

26 Jul 2022

Using genome editing to expand the possibilities of entomological research

Genome sequencing, where scientists use laboratory methods to determine a specific organism's genetic makeup, is becoming a common practice in insect research.

22 Jul 2022

Study assesses eight de novo genome assembly software tools on viral next-generation sequencing data

A new study compares and assesses eight de novo genome assembly software tools on actual viral next-generation sequencing data.

20 Jul 2022

Novel blood test offers unprecedented insight into a patient's cancer make-up

Researchers at the Vancouver Prostate Centre have developed a new blood test that provides unprecedented insight into a patient's cancer make-up, potentially allowing doctors to better select treatment options that will improve patient outcomes.

20 Jul 2022

Scientists provide first report from the largest whole genome sequencing effort to date

Scientists at deCODE genetics a subsidiary of Amgen together with collaborators from Denmark report on the whole genome sequences of 150 thousand participants in the UK biobank in a paper published in the journal Nature today.

20 Jul 2022

Study shows Omicron BA.4/5 infection triggers highly cross-reactive neutralizing antibodies

Researchers compared the levels of cross-reactive neutralizing antibodies elicited by SARS-CoV-2 Omicron BA.4 and BA.1 infections.

20 Jul 2022

Whole Genome Sequencing News and Research

Older heart muscle cells accumulate new genetic mutations -; while losing the ability to repair them

Mount Sinai and Regeneron Genetics Center launch a new human genome sequencing research project

What is the genomic diversity of SARS-CoV-2 infections in households?

Nearly three-quarters of all stem cell lines are affected by DNA damage, say researchers

A direct lineage-typing RT-PCR assay reveals insights into the transition from Omicron BA.1 to BA.2 dominance in Sweden

Evaluating vaccine effectiveness against Omicron BA.5 and BA.2 in Portugal

Serbia's genome center monitors potential virus mutations to facilitate more effective COVID-19 control

Insights into the products and services of Azenta

Early-life acquisition of antibiotic resistance in neonates from developing countries

Disease progression in the rhesus macaque model upon inoculation with the Delta, Omicron BA.1, and Omicron BA.2 variants

Children with intellectual disability of genetic origin are extremely likely to develop other neuropsychiatric conditions

What is the prevalence of carbapenem-resistant Enterobacterales among individuals with and without health risk factors?

How and when do de novo SARS-CoV-2 spike mutations emerge?

Comparing SARS-CoV-2 Omicron BA.2 and BA.5 vaccine breakthrough infections

Researchers assess UK biobank genome sequences

Using genome editing to expand the possibilities of entomological research

Study assesses eight de novo genome assembly software tools on viral next-generation sequencing data

Novel blood test offers unprecedented insight into a patient's cancer make-up

Scientists provide first report from the largest whole genome sequencing effort to date

Study shows Omicron BA.4/5 infection triggers highly cross-reactive neutralizing antibodies

Sequencing & Genomics: Elevating Science and Healthcare eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News